Valneva (NASDAQ:VALN) Shares Gap Up - Here's What Happened

Valneva SE (NASDAQ:VALN - Get Free Report)'s stock price gapped up prior to trading on Tuesday . The stock had previously closed at $7.00, but opened at $7.48. Valneva shares last traded at $7.54, with a volume of 18,726 shares.

Analyst Upgrades and Downgrades

• Novavax’s dispute resolution and upcoming earnings call

Separately, HC Wainwright reaffirmed a "buy" rating and set a $18.00 target price on shares of Valneva in a research report on Friday, January 31st.

Read Our Latest Stock Report on VALN

Valneva Stock Up 8.1 %

The business's fifty day moving average price is $4.63 and its two-hundred day moving average price is $5.63. The company has a debt-to-equity ratio of 0.70, a quick ratio of 2.25 and a current ratio of 2.78. The firm has a market capitalization of $615.14 million, a P/E ratio of -58.32 and a beta of 1.98.

Institutional Trading of Valneva

A hedge fund recently bought a new stake in Valneva stock. ABC Arbitrage SA purchased a new position in shares of Valneva SE (NASDAQ:VALN - Free Report) during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund purchased 19,244 shares of the company's stock, valued at approximately $84,000. 11.39% of the stock is currently owned by hedge funds and other institutional investors.

Valneva Company Profile

Valneva SE, a specialty vaccine company, develops, manufactures, and commercializes prophylactic vaccines for infectious diseases with unmet needs. It offers IXIARO, an inactivated Vero cell culture-derived Japanese encephalitis vaccine indicated for active immunization against Japanese encephalitis; DUKORAL, an oral vaccine for the prevention of diarrhea caused by Vibrio cholera and/or heat-labile toxin producing enterotoxigenic Escherichia coli bacterium; IXCHIQ, a single-dose, live-attenuated vaccine for the prevention of disease caused by chikungunya virus; and VLA2001, an inactivated whole-virus COVID-19 vaccine.

See Also

• Five stocks we like better than Valneva
• What Are Dividends? Buy the Best Dividend Stocks
• U.S. Steel: Will Trump-Backed Nippon Investment Drive Upside?
• Financial Services Stocks Investing
• Banking Stocks Lead the Week: Stronger Economy on the Horizon?
• Why Special Dividends Can be a Delightful Surprise for Income Investors
• 3 Stocks to Gain From the Rising Demand in Offshore Drilling

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Where Should You Invest $1,000 Right Now?

Before you make your next trade, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis.

Our team has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and none of the big name stocks were on the list.

They believe these five stocks are the five best companies for investors to buy now...

See The Five Stocks Here

Should You Invest $1,000 in Valneva Right Now?

Before you consider Valneva, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Valneva wasn't on the list.

While Valneva currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here